Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04124406

Recruitment Status : Active, not recruiting

First Posted : October 11, 2019

Last Update Posted : February 20, 2024

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborator:

Mayo Clinic

Information provided by (Responsible Party):

Exact Sciences Corporation

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Actual Primary Completion Date :	December 31, 2023
Estimated Study Completion Date :	December 2029

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Olson JE, Kirsch EJ, Edwards V DK, Kirt CR, Kneedler B, Laffin JJ, Weaver AL, St Sauver JL, Yost KJ, Finney Rutten LJ. Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study). BMJ Open Gastroenterol. 2020 Feb 19;7(1):e000353. doi: 10.1136/bmjgast-2019-000353. eCollection 2020.

To Top